Literature DB >> 21947613

Optical, structural and thermodynamic studies of the association of an anti-leucamic drug imatinib mesylate with transport protein.

Ashwini H Hegde1, Reeta Punith, J Seetharamappa.   

Abstract

The interaction of an anti-leukemic drug, imatinib mesylate (IMT) with human serum albumin (HSA) was investigated by fluorescence, synchronous fluorescence, three-dimensional fluorescence, circular dichroism and UV-vis absorption techniques under physiological condition. The process of binding of IMT on HSA was observed to be through a spontaneous molecular interaction procedure. IMT effectively quenched the intrinsic fluorescence of HSA via static quenching. The values of binding constant, number of molecules that interact simultaneously with the binding site and thermodynamic parameters were evaluated by carrying out the interactions at three different temperatures. Based on thermodynamic parameters and displacement studies with site probes, it was proposed that the drug bound at Sudlow's site I of subdomain IIA. The change in the conformation of HSA was evident from synchronous, three-dimensional fluorescence and circular dichroism studies. The distance between the donor (protein) and acceptor (drug) was calculated based on the Foster's theory of resonance energy stransfer and it was found to be 1.30 nm. The effect of different metal ions on the binding of the drug to protein was also investigated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947613     DOI: 10.1007/s10895-011-0986-0

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  14 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

Review 2.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

Authors:  Ulrich Kragh-Hansen; Victor Tuan Giam Chuang; Masaki Otagiri
Journal:  Biol Pharm Bull       Date:  2002-06       Impact factor: 2.233

3.  Part I: Milestones in personalised medicine--imatinib.

Authors:  Carlo Gambacorti-Passerini
Journal:  Lancet Oncol       Date:  2008-06       Impact factor: 41.316

4.  Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion.

Authors:  S S Lehrer
Journal:  Biochemistry       Date:  1971-08-17       Impact factor: 3.162

5.  Oxygen quenching of pyrenebutyric acid fluorescence in water. A dynamic probe of the microenvironment.

Authors:  W M Vaughan; G Weber
Journal:  Biochemistry       Date:  1970-02-03       Impact factor: 3.162

6.  Thermodynamics of protein association reactions: forces contributing to stability.

Authors:  P D Ross; S Subramanian
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

7.  Crystal structure of human serum albumin at 2.5 A resolution.

Authors:  S Sugio; A Kashima; S Mochizuki; M Noda; K Kobayashi
Journal:  Protein Eng       Date:  1999-06

8.  Investigation of the interaction between colloidal TiO(2) and bovine hemoglobin using spectral methods.

Authors:  Yan-Qing Wang; Hong-Mei Zhang; Rong-Hua Wang
Journal:  Colloids Surf B Biointerfaces       Date:  2008-04-15       Impact factor: 5.268

9.  Conjugated polyene fatty acids as fluorescent probes: synthetic phospholipid membrane studies.

Authors:  L A Sklar; B S Hudson; R D Simoni
Journal:  Biochemistry       Date:  1977-03-08       Impact factor: 3.162

10.  Spectroscopic analysis of the binding interaction between tinidazole and bovine serum albumin (BSA).

Authors:  Xin Yu Shi; Hui Cao; Feng Lian Ren; Ming Xu
Journal:  Chem Biodivers       Date:  2007-12       Impact factor: 2.408

View more
  2 in total

1.  Binding properties of food colorant allura red with human serum albumin in vitro.

Authors:  Langhong Wang; Guowen Zhang; Yaping Wang
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

2.  Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib.

Authors:  Svenja Beckmann; Thavy Long; Christina Scheld; Rudolf Geyer; Conor R Caffrey; Christoph G Grevelding
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-07       Impact factor: 4.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.